CAS: 2641998-63-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RMC-6291 REF: IN-DA027SB8CAS: 2641998-63-0 | 98% | To inquire | Mon 16 Dec 24 |
 | RMC-6291 REF: TM-T75131CAS: 2641998-63-0 | 98.73% | 159.00 €~3,048.00 € | Tue 17 Dec 24 |
RMC-6291
CAS:2641998-63-0
Formula:
C55H78FN9O8
Purity:
98%
Color and Shape:
Solid
Molecular weight:
1012.2617
Ref: IN-DA027SB8
| 1mg | 504.00 € | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
RMC-6291
CAS:2641998-63-0
RMC-6291: Oral, covalent KRAS G12C inhibitor, blocks signaling, forms tri-complex with CypA, suppresses RAS activity …
Formula:
C55H78FN9O8
Purity:
98.73%
Color and Shape:
Liquid
Molecular weight:
1012.26
Ref: TM-T75131
| 1mg | 159.00 € | ||
| 2mg | 225.00 € | ||
| 5mg | 370.00 € | ||
| 10mg | 631.00 € | ||
| 25mg | 1,114.00 € | ||
| 50mg | 1,869.00 € | ||
| 100mg | 3,048.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
